Cap Raise

So we know the company are seeking funds for the next phase of the trials and general day to day funds. Our two major shareholders own as of last top 20 over 30% of shares on issue. Top 10 holds hold over 50%. Top 20 over 70%. There is next to no retail buying here. The people holding are here for the phase 2/3 trials and the potential game changer in medicine that would come from safe,measured, non-addictive easy to use pain or anxiety relief medication. I dont see why we would raise below 4c. The company in my opinion would look to raise enough to keep us going till this time next year with say 1.5 to 2 million dollars and with good trial results look for a tie up with big pharma or potentially big tobacco. We will know soon enough.....